WDYHV1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.030000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.853600E-01
Normal-vs-Stage2
6.089600E-01
Normal-vs-Stage3
8.398400E-01
Normal-vs-Stage4
6.657600E-01
Stage1-vs-Stage2
6.081000E-01
Stage1-vs-Stage3
7.085000E-01
Stage1-vs-Stage4
7.702000E-01
Stage2-vs-Stage3
3.955600E-01
Stage2-vs-Stage4
9.089600E-01
Stage3-vs-Stage4
5.379400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.922400E-01
Normal-vs-AfricanAmerican
8.295600E-01
Normal-vs-Asian
6.245200E-01
Caucasian-vs-AfricanAmerican
6.889900E-02
Caucasian-vs-Asian
7.508200E-01
AfricanAmerican-vs-Asian
3.716600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.775800E-01
Normal-vs-Female
6.345200E-01
Male-vs-Female
2.607600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.216800E-01
Normal-vs-Age(41-60Yrs)
2.812400E-01
Normal-vs-Age(61-80Yrs)
7.293200E-01
Normal-vs-Age(81-100Yrs)
6.099000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.747700E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.121800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.389400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.747800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.291600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.090200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.737000E-01
Normal-vs-Daily Drinker
4.916600E-01
Normal-vs-Weekly Drinker
6.167600E-01
Normal-vs-Occasional Drinker
1.692620E-01
Normal-vs-Social Drinker
9.903400E-01
Non Drinker-vs-Daily Drinker
6.204000E-01
Non Drinker-vs-Weekly Drinker
9.157000E-01
Non Drinker-vs-Occasional Drinker
5.319700E-02
Non Drinker-vs-Social Drinker
4.033600E-01
Daily Drinker-vs-Weekly Drinker
5.646000E-01
Daily Drinker-vs-Occasional Drinker
1.414430E-01
Daily Drinker-vs-Social Drinker
1.890190E-01
Weekly Drinker-vs-Occasional Drinker
5.302400E-02
Weekly Drinker-vs-Social Drinker
4.233000E-01
Occasional Drinker-vs-Social Drinker
1.018070E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.121200E-01
Normal-vs-Grade 2
1.485190E-01
Normal-vs-Grade 3
1.514640E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.468600E-01
Grade 1-vs-Grade 3
7.899800E-01
Grade 1-vs-Grade 4
5.121200E-01
Grade 2-vs-Grade 3
9.840200E-02
Grade 2-vs-Grade 4
1.485190E-01
Grade 3-vs-Grade 4
1.514640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.540000E-01
Normal-vs-NonDiabetic
5.503600E-01
Diabetic-vs-NonDiabetic
4.067200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.587200E-01
Normal-vs-NoPancreatitis
5.866800E-01
Pancreatitis-vs-NoPancreatitis
3.118400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.363800E-01
Normal-vs-N1
6.298600E-01
N0-vs-N1
1.690180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.008400E-01
Normal-vs-TP53-NonMutant
9.156400E-01
TP53-Mutant-vs-TP53-NonMutant
1.230140E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
